William T. Andrews
CIK 1638459 · Chief Medical Officer · last filed 2026-06-05
William T. Andrews is a Chief Medical Officer who has filed 13 SEC Form 4 insider transactions across 6 companies since 2015. The most recent filing, for CPRX, was dated Jun 5, 2026. Current disclosed insider exposure totals $95.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$95.7K
6
13
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CPRX | Chief Medical Officer | 3,052 | $31.36 | $95.7K | $0 | 2 | 2026-06-05 |
| FLXN | Chief Medical Officer | 0 | $25.05 | $0 | $0 | 2 | 2021-11-19 |
| AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Chief Medical Officer | 0 | — | — | $0 | 2 | 2020-10-13 |
| Acer Therapeutics Inc. (ACER) Delisted | Chief Medical Officer | 5,858 | $0.66 | $3.9K | $0 | 4 | 2020-03-04 |
| Acer Therapeutics Inc. (ACERW) Delisted | Chief Medical Officer | — | — | — | $0 | 1 | 2017-10-06 |
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | See Remarks | — | — | — | $0 | 2 | 2015-08-06 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | CPRX | Mixed | +2,309 | $0 | EDGAR |
| 2025-11-24 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2021-11-19 | FLXN | Disp (D) | −34,250 | -$291.1K | EDGAR |
| 2021-08-04 | FLXN | Grant (A) | +34,250 | $0 | EDGAR |
| 2020-10-13 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Mixed | −37,500 | -$680.6K | EDGAR |
| 2020-07-10 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Grant (A) | +37,500 | $0 | EDGAR |
| 2020-03-04 | Acer Therapeutics Inc. (ACER) Delisted | Tax (F) | −3,142 | -$10.3K | EDGAR |
| 2019-09-23 | Acer Therapeutics Inc. (ACER) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-05 | Acer Therapeutics Inc. (ACER) Delisted | Grant (A) | +9,000 | $0 | EDGAR |
| 2019-02-05 | Acer Therapeutics Inc. (ACER) Delisted | Grant (A) | — | $0 | EDGAR |